RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 12-22
  • New medicine offers another defense in the asthma war

    With the summer weather so unbelievably pleasant in the Lehigh Valley in recent weeks, it's been easy to forget how difficult it is for some folks to breathe around here. The good news for them is that they just got new help in their war against asthma....
  • Extreme medicine: The search for new antibiotics

    NORWICH England (Reuters) - Pampering leafcutter ants with fragrant rose petals and fresh oranges may seem an unlikely way to rescue modern medicine, but scientists at a lab in eastern England think it's well worth trying.     As the world cries out...
  • P&G eyes Duracell, Braun in sweeping brand culling: sources

    NEW YORK (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said....
  • U.S. speeds up human clinical trials for promising Ebola vaccine

    U.S. speeds up human clinical trials for promising Ebola vaccine
    Researchers at the National Institutes of Health are accelerating human clinical trials for what scientists hope is a promising new vaccine to combat the deadly Ebola virus. Phase 1 of the clinical trials, which were previously not expected to begin...
  • Canada's Immunovaccine Inc says test of Ebola vaccine promising

    WINNIPEG Manitoba (Reuters) - Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc's technology, the tiny Canadian company said on Monday, and the announcement sent its stock soaring. The Halifax, Nova...
  • India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden

    MUMBAI (Reuters) - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be...
  • U.S. contract approved to speed tests of Mapp's Ebola drug

    (Reuters) - The U.S. Department of Health and Human Services said on Tuesday a federal contract worth up to $42.3 million would help accelerate testing of an experimental Ebola virus treatment that is being developed by privately held Mapp...
  • Paciente británico de ébola es dado de alta en hospital luego de tratamiento con ZMapp

    LONDRES (Reuters) - Un británico que contrajo ébola en África Occidental ha sido dado de alta después de un exitoso tratamiento con el medicamento experimental ZMapp, informó el miércoles el Royal Free Hospital de Londres. William Pooley, de 29 años, fue...
  • British Ebola patient out of hospital after receiving experimental drug

    British Ebola patient out of hospital after receiving experimental drug
    A British man who contracted Ebola in West Africa has been discharged after successful treatment with the experimental ZMapp drug, the Royal Free Hospital in London said Wednesday. William Pooley, 29, was treated in a special isolation unit after...
  • Chimerix says antiviral shows promise against Ebola

    (Reuters) - Chimerix Inc said its lead experimental drug showed promise against the deadly Ebola virus in laboratory testing at the U.S. Centers for Disease Control and Prevention and the National Institutes of Health. The company joins a rapidly growing...
  • Ebola vaccine from GSK fast-tracked into clinical trials

    LONDON/NEW YORK (Reuters) - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build a stockpile of up to 10,000 doses for emergency deployment, if results are good. The research work...